Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2851 AL 2865

Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review

Alqarni S, Alsebai M.

Front Endocrinol (Lausanne). 2022 Dec 22;13:1032192. doi: 10.3389/fendo.2022.1032192. eCollection 2022.

Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases

Sivagurunathan N, Ambatt ATS, Calivarathan L.

Curr Aging Sci. 2022;15(2):84-96. doi: 10.2174/1874609815666220126095847.

Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detection

Goldoni R, Dolci C, Boccalari E, Inchingolo F, Paghi A, Strambini L, Galimberti D, Tartaglia GM.

Ageing Res Rev. 2022 Apr;76:101587. doi: 10.1016/j.arr.2022.101587. Epub 2022 Feb 11.

The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS - a critical overview

Bernstein HG, Keilhoff G, Dobrowolny H, Steiner J.

Rev Neurosci. 2022 Jul 1;34(1):1-24. doi: 10.1515/revneuro-2022-0026. Print 2023 Jan 27.

The Key Role of Magnetic Resonance Imaging in the Detection of Neurodegenerative Diseases-Associated Biomarkers: A Review

Li KR, Wu AG, Tang Y, He XP, Yu CL, Wu JM, Hu GQ, Yu L.

Mol Neurobiol. 2022 Oct;59(10):5935-5954. doi: 10.1007/s12035-022-02944-x. Epub 2022 Jul 12.

Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases

Sataer X, Qifeng Z, Yingying Z, Chunhua H, Bingzhenga F, Zhiran X, Wanli L, Yuwei Y, Shuangfeng C, Lingling W, Hongri H, Jibing C, Xiaoping R, Hongjun G.

Neurol Res. 2023 Mar;45(3):191-199. doi: 10.1080/01616412.2022.2129768. Epub 2022 Oct 2.

Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases

Xia X, Wang Y, Zheng JC.

Transl Neurodegener. 2022 Dec 12;11(1):53. doi: 10.1186/s40035-022-00330-0.

Melatonin Receptor as a Drug Target for Neuroprotection

Wongprayoon P, Govitrapong P.

Curr Mol Pharmacol. 2021;14(2):150-164. doi: 10.2174/1874467213666200421160835.

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases

Mayo S, Benito-León J, Peña-Bautista C, Baquero M, Cháfer-Pericás C.

Curr Neuropharmacol. 2021;19(8):1273-1303. doi: 10.2174/1570159X19666201223154009.

Editorial to the Special Issue "Lipidomics and Neurodegenerative Diseases"

Calvano CD, Losito I, Cataldi T.

Int J Mol Sci. 2021 Jan 28;22(3):1270. doi: 10.3390/ijms22031270.

Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias

Cicognola C, Hansson O, Scheltens P, Kvartsberg H, Zetterberg H, Teunissen CE, Blennow K.

Alzheimers Res Ther. 2021 Feb 8;13(1):38. doi: 10.1186/s13195-020-00756-6.

Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression

Krokidis MG, Exarchos TP, Vlamos P.

Math Biosci Eng. 2021 Feb 22;18(2):1813-1832. doi: 10.3934/mbe.2021094.

Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson's disease

Giri B, Seamon M, Banerjee A, Chauhan S, Purohit S, Morgan J, Baban B, Wakade C.

Metab Brain Dis. 2022 Aug;37(6):1687-1696. doi: 10.1007/s11011-021-00735-2. Epub 2021 Apr 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias